Published in Clin Infect Dis on July 01, 2009
Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev (2011) 2.08
Fungal biofilm resistance. Int J Microbiol (2012) 1.73
Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One (2011) 1.57
Emerging pan-resistance in Trichosporon species: a case report. BMC Infect Dis (2016) 1.45
Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts. PLoS One (2014) 1.14
Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections? Biomed Res Int (2015) 1.07
Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol (2011) 0.97
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol (2013) 0.96
The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort. BMC Pulm Med (2013) 0.96
Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. PLoS One (2014) 0.92
Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin Infect Dis (2009) 0.89
Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014. Open Forum Infect Dis (2015) 0.84
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin. Virulence (2015) 0.80
In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii. PLoS One (2016) 0.77
A rare case of urinary tract infection due to Trichosporon asahii in a diabetic patient. Pan Afr Med J (2015) 0.75
Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery. Med Mycol Case Rep (2015) 0.75
Fungemia due to Trichosporon dermatis in a patient with refractory Burkitt's leukemia. Blood Res (2013) 0.75
Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system. Eur J Clin Microbiol Infect Dis (2014) 0.75
Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis (2007) 6.20
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study. Crit Care Med (2015) 2.91
Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med (2012) 2.87
Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis (2005) 2.84
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J (2013) 2.80
Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother (2012) 2.65
Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother (2011) 2.30
Occult Staphylococcus aureus bacteremia in adult emergency department patients: rare but important. Clin Infect Dis (2012) 1.97
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters. Clin Infect Dis (2012) 1.96
Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis (2007) 1.91
High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents (2011) 1.90
Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis (2011) 1.85
Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J Antimicrob Chemother (2007) 1.84
High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis (2005) 1.81
High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med (2011) 1.80
Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis (2008) 1.79
High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother (2003) 1.75
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother (2006) 1.74
Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother (2008) 1.73
Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis. Clin Infect Dis (2012) 1.68
Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis (2008) 1.67
Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol (2004) 1.67
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother (2009) 1.64
Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008. J Infect (2012) 1.57
Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions. Int J Antimicrob Agents (2012) 1.56
Lower gastrointestinal tract tuberculosis: an important but neglected disease. Int J Colorectal Dis (2009) 1.55
Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax (2012) 1.55
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother (2005) 1.55
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents (2012) 1.54
Meningitis due to Histoplasma capsulatum and Mycobacterium tuberculosis in a returned traveler with acquired immunodeficiency syndrome. J Formos Med Assoc (2005) 1.51
Streptococcus suis infection. J Microbiol Immunol Infect (2005) 1.51
Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae. Crit Care Med (2008) 1.50
Risk factors for nasal carriage of methicillin-resistant Staphylococcus aureus among patients with end-stage renal disease in Taiwan. J Formos Med Assoc (2012) 1.46
groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci. J Clin Microbiol (2002) 1.45
Vibrio cholerae O1 infection in Taiwan. J Infect (2010) 1.45
Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob Chemother (2011) 1.44
New Delhi metallo-ß-lactamase-1 (NDM-1): an emerging threat among Enterobacteriaceae. J Formos Med Assoc (2010) 1.44
Hypoglycemia associated with bacteremic pneumococcal infections. Int J Infect Dis (2008) 1.43
Diagnostic performance of whole-blood interferon-γ assay and enzyme-linked immunospot assay for active tuberculosis'. Diagn Microbiol Infect Dis (2011) 1.40
Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species. J Antimicrob Chemother (2009) 1.39
Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother (2010) 1.39
Current challenges in the management of invasive fungal infections. J Infect Chemother (2008) 1.38
Disseminated tuberculosis: a 10-year experience in a medical center. Medicine (Baltimore) (2007) 1.31
Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis (2007) 1.31
Subcutaneous abscess caused by Mycobacterium conceptionense in an immunocompetent patient. J Infect (2009) 1.30
Tenosynovitis caused by Mycobacterium arupense in a patient with diabetes mellitus. Clin Infect Dis (2008) 1.27
Community-acquired methicillin-resistant Staphylococcus aureus in children in northern Taiwan. J Microbiol Immunol Infect (2004) 1.26
Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis (2007) 1.25
Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother (2011) 1.25
Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons. J Antimicrob Chemother (2006) 1.23
Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother (2013) 1.22
Extended-spectrum beta-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother (2006) 1.22
Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J Antimicrob Chemother (2011) 1.20
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. J Antimicrob Chemother (2009) 1.19
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agents Chemother (2008) 1.19
Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species. Antimicrob Agents Chemother (2011) 1.19
The erm(T) gene is flanked by IS1216V in inducible erythromycin-resistant Streptococcus gallolyticus subsp. pasteurianus. Antimicrob Agents Chemother (2005) 1.18
Bacteremia caused by non-faecalis and non-faecium enterococcus species at a Medical center in Taiwan, 2000 to 2008. J Infect (2010) 1.18
Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents (2009) 1.17
High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Int J Antimicrob Agents (2006) 1.16
Time to blood culture positivity as a predictor of methicillin resistance in Staphylococcus aureus bacteremia. J Infect (2010) 1.15
Matrix-assisted laser desorption ionization-time of flight mass spectrometry can accurately differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (sensu stricto). J Clin Microbiol (2013) 1.15
Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int J Antimicrob Agents (2011) 1.15
Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002. J Formos Med Assoc (2004) 1.14
Antimicrobial-resistant nocardia isolates, Taiwan, 1998-2009. Clin Infect Dis (2011) 1.14
High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob Agents Chemother (2009) 1.14
Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000-2012. Emerg Infect Dis (2014) 1.13
Time to positivity in blood cultures of staphylococci: clinical significance in bacteremia. J Infect (2011) 1.12
Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis (2004) 1.12
Bacteremia caused by group G Streptococci, taiwan. Emerg Infect Dis (2008) 1.11
An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int J Infect Dis (2004) 1.11
Clinical and microbiological characteristics of Rhizobium radiobacter infections. Clin Infect Dis (2003) 1.11
Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan. Antimicrob Agents Chemother (2011) 1.10
BactQuant: an enhanced broad-coverage bacterial quantitative real-time PCR assay. BMC Microbiol (2012) 1.10
Catheter-related bacteremia caused by Staphylococcus pseudintermedius refractory to antibiotic-lock therapy in a hemophilic child with dog exposure. J Clin Microbiol (2010) 1.10
Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. J Med Virol (2004) 1.09
Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis (2004) 1.09
Infected bronchogenic cyst due to Mycobacterium avium in an immunocompetent patient. J Infect (2004) 1.08
Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother (2009) 1.07
Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc (2009) 1.07
Pelvic abscess caused by New Delhi metallo-β-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China. Diagn Microbiol Infect Dis (2011) 1.07
Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance. Clin Infect Dis (2004) 1.06
Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med (2006) 1.06
Clinical characteristics of infections caused by Tsukamurella spp. and antimicrobial susceptibilities of the isolates. Int J Antimicrob Agents (2011) 1.06
Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock (2008) 1.06
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan. Microb Drug Resist (2005) 1.06
Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital. J Antimicrob Chemother (2002) 1.05
Mycobacterium celatum pulmonary infection mimicking pulmonary tuberculosis in a patient with ankylosing spondylitis. Int J Infect Dis (2009) 1.05
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother (2010) 1.05
Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011. Antimicrob Agents Chemother (2012) 1.04
Bacteremia caused by Salmonella enterica serotype Choleraesuis in Taiwan. J Microbiol Immunol Infect (2006) 1.04
Clonality despite sex: the evolution of host-associated sexual neighborhoods in the pathogenic fungus Penicillium marneffei. PLoS Pathog (2012) 1.04
Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method. Antimicrob Agents Chemother (2007) 1.04
In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) (2009) 1.04
Clinical features and outcomes of disseminated infections caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 2004-2008. Scand J Infect Dis (2010) 1.04
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother (2011) 1.04